# Synbiotic Therapy for NP-PASC

> **NCT06620406** · NA · COMPLETED · sponsor: **Columbia University** · enrollment: 36 (actual)

## Conditions studied

- Post-Acute COVID-19 Syndrome
- Long COVID-19

## Interventions

- **DIETARY_SUPPLEMENT:** Synbiotic IVS-1
- **DIETARY_SUPPLEMENT:** Maltodextrin

## Key facts

- **NCT ID:** NCT06620406
- **Lead sponsor:** Columbia University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-12-09
- **Primary completion:** 2025-08-06
- **Final completion:** 2025-08-06
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2025-08-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06620406

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06620406, "Synbiotic Therapy for NP-PASC". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06620406. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*